Gfs Advisors, LLC Abb Vie Inc. Transaction History

Gfs Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $192,903 - $218,974	-1,813 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $190,745 - $212,501	1,813 New	1,813 $204,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $222,363 - $247,198	-2,501 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $1,564 - $2,094	-17 Reduced 0.68%	2,501 $237,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $225,512 - $247,292	2,518 New	2,518 $244,000
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $785,672 - $1 Million	-11,248 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	11,248	11,248 $816,000

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfs Advisors, LLC with notifications on news.